[AMRX] YoY Annual Result on 31-Dec-2017 [#FY]

Stock
[AMRX] Amneal Pharmaceuticals, Inc.
Announcement Date
09-Mar-2018
Financial Year
2017
Quarter
31-Dec-2017 [#FY]
Profit Trend
YoY- -19.16%
Quarter Report
AMRX's Result
AMRX's Financial Summary
View:
Show?
Annual Result
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 1,992,523 1,626,373 1,662,991 1,033,654 1,018,225 866,280 785,623 16.76%
PBT -35,780 -220,242 -202,722 171,323 214,821 175,582 179,331 -
Tax -104,358 383,331 -1,419 1,998 5,395 4,951 1,513 -
NP 68,578 -603,573 -169,726 167,648 207,378 169,451 176,928 -14.59%
Tax Rate - - - -1.17% -2.51% -2.82% -0.84% -
Total Cost 1,923,945 2,229,946 1,832,717 866,006 810,847 696,829 608,695 21.12%
Ratio Analysis
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin 3.44 -37.11 -10.21 16.22 20.37 19.56 22.52 -26.86%
Per Share
31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS 0.47 -4.57 -1.33 1.46 1.81 0.90 0.00 -
EPS Diluted 0.46 -4.57 -1.33 1.46 1.81 0.90 0.00 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.